HemoCue Glucose 201 Point-of-Care Glucose Analyzer, Promotion with Microcuvettes 50 Test CLIA Waived , Hemocue G11217

HemoCue Glucose 201 Point-of-Care Glucose Analyzer, Promotion with Microcuvettes 50 Test CLIA Waived , Hemocue G11217

Manufacturer # G11217 Brand HemoCue® Glucose 201 Manufacturer Hemocue Application Point-of-Care Glucose Analyzer, Promotion CLIA Classification CLIA Waived Dimensions 3.35 X 6.30 X 1.69 Inch For Use With HemoCue® Glucose 201 Microcuvette Kit Contents Analyzer, 1 Box Glucose 201 Microcuvettes (50 Tests), 1 Set of Controls Number of Tests 50 Test Readout Type Digital Display Sample Type Capillary / Venous / Aterial Whole Blood Sample Test Name Blood Glucose Level Test Time 4 Minute Results UNSPSC Code 41115808 Weight 0.77 lbs. Features

CLIA-Waived glucose analyzer for in-office screening, diagnosing and monitoring diabetes Hemocue glucose testing systems are based on a glucose dehydrogenase method and consist of a small dedicated analyzer and a unique disposable microcuvette No calibration or microcuvette batch-to-batch variations Glucose 201 analyzer: 0-444 mg/dl (0-24.6 mmol/l) Only 5 µL of capillary, venous, or arterial blood is needed Following the three simple steps, the hemocue glucose systems will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels